Ocean Biomedical, Inc.
Extracted from this filing and checked against the source text.
Ocean Biomedical, Inc. amended Definitive A&R Backstop Agreement with Aesther, Ocean Biomedical, Vellar Opportunity Fund SPV LLC – Series 3 (effective 2023-02-12).
On February 12, 2023, Aesther, Ocean Biomedical and Vellar again amended and restated the Original Backstop Agreement (the “ Definitive A&R Backstop Agreement ”)View on SEC.gov
Ocean Biomedical, Inc. entered into Agreement and Plan of Merger with Aesther Healthcare Acquisition Corp., AHAC Merger Sub, Inc., Aesther Healthcare Sponsor, LLC, Ocean Biomedical, Inc., Dr. Chirinjeev Kathuria (effective 2022-08-31).
On August 31, 2022, Aesther Healthcare Acquisition Corp., a Delaware corporation (“ Aesther ”) entered into an Agreement and Plan of Merger by and among Aesther, AHAC Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Aesther (“ Merger Sub ”), Aesther Healthcare Sponsor, LLC, Aesther’s sponsor (the “ Sponsor ”), in its capacity as purchaser representative, Ocean Biomedical, Inc., a Delaware corporation (“ Ocean Biomedical ”), and Dr. Chirinjeev Kathuria, in his capacity as seller representative (as may be amended and/or restated from time to time, the “ Merger Agreement ”)View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.